You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage IIB or III squamous cell esophageal carcinoma.

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-metastatic, Non-recurrent Lung and Esophageal Cancer

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +55 more
  • Biospecimen Collection
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 5, 2023

Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +85 more
  • Patient Monitoring System
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Sep 7, 2022

Remote Telemonitoring of Patient-Generated Physiologic Health

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +171 more
  • Patient Monitoring
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage

Recruiting
  • Clinical Stage I Esophageal Adenocarcinoma AJCC v8
  • +66 more
  • Phoenix, Arizona
  • +76 more
Jan 11, 2023

Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma

Recruiting
  • Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +18 more
  • Duarte, California
    City of Hope Medical Center
Feb 16, 2022

Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • no intervention
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jul 29, 2023

Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
  • (no location specified)
Mar 17, 2023

Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shijiazhuang, Hebei, China
      Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
    Oct 25, 2023

    Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

    Not yet recruiting
    • Esophageal Cancer
    • +2 more
    • (no location specified)
    Aug 21, 2023

    Esophageal Squamous Cell Carcinoma Trial in Nanjing (Carrelizumab, Paclitaxel injection, Cisplatin)

    Enrolling by invitation
    • Esophageal Squamous Cell Carcinoma
    • Nanjing, China
      The First Affiliated Hospital of Nanjing Medical University
    Sep 19, 2023

    Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical

    Not yet recruiting
    • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
    • +11 more
    • Acupressure Therapy
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jun 12, 2023

    Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

    Recruiting
    • Metastatic Esophageal Squamous Cell Carcinoma
    • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
    • Qingdao, Shandong, China
    • +1 more
    Nov 13, 2023

    Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)

    Recruiting
    • Neoadjuvent
    • +3 more
    • Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
    • Xi'an, Shaanxi, China
    • +2 more
    Aug 17, 2023

    Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Nov 30, 2023

    Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Head and Neck Squamous Cell Carcinoma
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Oct 25, 2023

    Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

    Not yet recruiting
    • Advanced Esophageal Squamous Carcinoma With Oligometastases
    • simultaneous with radiotherapy
    • synchronous with radiotherapy
    • (no location specified)
    Nov 16, 2023

    Esophageal Squamous Cell Carcinoma Abdominal Stage 0 Trial in Guangzhou (PD-1 Inhibitors, Irinotecan, Capecitabine tablets)

    Recruiting
    • Esophageal Squamous Cell Carcinoma Abdominal Stage 0
    • PD-1 Inhibitors
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Feb 20, 2023

    ctDNA-MRD in Predicting Efficacy of Esophageal Squamous Cell

    Not yet recruiting
    • Squamous Cell Carcinoma of Esophagus
      • (no location specified)
      Feb 25, 2023

      ESCC Trial (Tislelizumab combined with chemoradiotherapy)

      Not yet recruiting
      • ESCC
      • Tislelizumab combined with chemoradiotherapy
      • (no location specified)
      Sep 18, 2022

      The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

      Recruiting
      • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
      • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
      • Hanzhou, Zhejiang, China
        Lulu Liu
      Jul 14, 2023

      Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma
      • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
      • (no location specified)
      Aug 17, 2023

      Esophageal Squamous Cell Carcinoma Stage II, Esophageal Squamous Cell Carcinoma Stage III Trial in Shanghai (Neoadjuvant

      Recruiting
      • Esophageal Squamous Cell Carcinoma Stage II
      • Esophageal Squamous Cell Carcinoma Stage III
      • Neoadjuvant Chemoradiotherapy
      • +2 more
      • Shanghai, China
        Shanghai Zhongshan Hospital
      Jun 26, 2022

      Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

      Not yet recruiting
      • Minimal Residual Disease
      • Esophageal Squamous Cell Carcinoma
        • Guangzhou, Guangdong, China
          Guangdong Provincial People's Hospital
        Jun 10, 2023

        Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • (no location specified)
        Aug 28, 2023

        Esophageal Squamous Cell Carcinoma Trial in Wuhan (Intensity-modulated radiotherapy (IMRT), Tislelizumab, Cisplatin)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • Intensity-modulated radiotherapy (IMRT)
        • +3 more
        • Wuhan, Hubei, China
          Renmin hosptial of Wuhan University
        Jun 16, 2023